Tech Center 1600 • Art Units: 1611 1614 1617 1619
This examiner grants 60% of resolved cases
Genevieve S Alley handles cases in Tech Center 1600 and Art Unit 1611. With 736 resolved cases, the allowance rate is 60.3 percent, showing a positive trend for applicants. This 60.3 percent rate indicates that the majority of the 736 cases are successful. The data reflects a stable prosecution environment.
The interview lift is 48.2 percent, which is a high figure that suggests interviews are extremely effective. The median days to allowance is 1066, which is a standard timeframe for reaching a grant. Practitioners should prioritize interviews to capitalize on the 48.2 percent lift and improve the 60.3 percent allowance rate. The 1066-day timeline provides a predictable schedule for reaching a resolution. These metrics indicate that direct communication with the examiner is a highly successful tactic for securing a patent grant in this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18284625 | NON-ELUTABLE ANTIMICROBIAL GLASS COMPOSITION, AND METHOD FOR PREPARING ANTIMICROBIAL GLASS POWDER USING SAME | Non-Final OA | LG ELECTRONICS INC. |
| 18835879 | METAL EFFECT PIGMENTS WITH SURFACE-TREATMENTS, PREPARING METHOD AND USE OF SAME | Non-Final OA | MERCK PATENT GmbH |
| 18589817 | SKIN PENETRATION IMPROVER | Final Rejection | KANEKA CORPORATION |
| 18727863 | POTASSIUM-SODIUM TARTRATE AS GRANULATING AID | Non-Final OA | BASF SE |
| 18716697 | Herbicidal Compositions | Final Rejection | Syngenta Crop Protection AG |
| 18626620 | NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF | Final Rejection | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18721056 | COMPOSITION COMPRISING HYDROPHOBICIZED POLYION COMPLEX PARTICLE | Non-Final OA | L'Oreal |
| 18711436 | COSMETIC COMPOSITION FOR CARING FOR THE SKIN | Final Rejection | L'OREAL |
| 18600263 | NANOFIBER AND MICROFIBER HYBRID AEROGELS | Final Rejection | Board of Regents of the University of Nebraska |
| 17629854 | ALGINATE-BASED FACIAL MASK | Non-Final OA | BEIERSDORF AG |
| 18750592 | NANOPARTICLE (NP)-ENHANCED EXPRESSION OF AQUAPORIN-4 CHANNELS AND WATER TRANSPORT IN HUMAN ASTROCYTES | Final Rejection | The Government of the United States of America, as represented by the Secretary of the Navy |
| 18695864 | EFFERVESCENT CLEANSING POWDER COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18892456 | Indane Derivatives for Malodor Counteraction | Non-Final OA | Firmenich SA |
| 18579422 | METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL | Final Rejection | Omya International AG |
| 18711261 | METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS | Non-Final OA | Christiana Care Gene Editing Institute, Inc. |
| 17714025 | SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF | Non-Final OA | VAXESS TECHNOLOGIES, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy